Tirzepatide, a groundbreaking therapy, represents a significant step forward in the approach of type 2 diabetes and, more recently, excess body fat. This dual agonist acts upon two crucial hormones: incretin hormone and GIP. Unlike traditional blood sugar medications, Tirzepatide encourages not only insulin secretion when blood sugar concentrations